EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 41 filers reported holding EVELO BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,568,000 | -42.5% | 632,582 | -13.7% | 0.38% | -50.3% |
| Q3 2019 | $4,469,000 | -25.7% | 732,582 | +9.4% | 0.77% | +7.2% |
| Q2 2019 | $6,011,000 | +15.4% | 669,382 | +2.8% | 0.72% | +14.7% |
| Q1 2019 | $5,209,000 | -1.7% | 651,077 | +59.9% | 0.63% | -12.9% |
| Q4 2018 | $5,297,000 | +6.8% | 407,171 | 0.0% | 0.72% | +36.9% |
| Q3 2018 | $4,959,000 | -4.0% | 407,171 | -6.9% | 0.53% | -8.8% |
| Q2 2018 | $5,163,000 | – | 437,500 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 484,953 | $1,823,000 | 4.61% |
| Flagship Pioneering Inc. | 18,233,403 | $68,558,000 | 3.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $6,622,000 | 3.20% |
| Alphabet Inc. | 1,060,495 | $3,982,000 | 0.26% |
| Larson Financial Group LLC | 20,042 | $75,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,500 | $501,000 | 0.01% |
| CREDIT SUISSE AG/ | 1,500,117 | $5,633,000 | 0.01% |
| FMR LLC | 3,220,853 | $12,094,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 177,856 | $668,000 | 0.00% |
| Legal & General Group Plc | 1,522 | $6,000 | 0.00% |